Anna M Mc Laughlin (Anna Mueller-Schoell)

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Venues

Clinical pharmacology and therapeutics

Journal for immunotherapy of cancer

Cancers

BMJ open

PharMetrX Graduate Research Training Program

This page only lists publications with an associated author ORCID identifier.

Affiliation History

PharMetrX Graduate Research Training Program Aug 01 2018

Germany

PhD Student

Freie Universität Berlin Institut für Pharmazie Aug 01 2018

Germany

PhD Student :: Department of Clinical Pharamacy and Biochemistry

Publications

Anna M Mc Laughlin, Thomas Helland, Fenja Klima, Stijn L W Koolen, Ron H N van Schaik, Ron H J Mathijssen, Patrick Neven, Jesse Joachim Swen, Henk-Jan Guchelaar, Florence Dalenc, Melanie White-Koning, Robin Michelet, Gerd Mikus, Werner Schroth, Thomas Mürdter, Hiltrud B Brauch, Matthias Schwab, Håvard Søiland, Gunnar Mellgren, Fabienne Thomas, Charlotte Kloft, Daniel Louis Hertz, null null
Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM Cohort. Clinical pharmacology and therapeutics (2024)
Anna M Mc Laughlin, Thomas Helland, Fenja Klima, Stijn L W Koolen, Ron H N van Schaik, Ron H J Mathijssen, Patrick Neven, Jesse Joachim Swen, Henk-Jan Guchelaar, Florence Dalenc, Melanie White-Koning, Robin Michelet, Gerd Mikus, Werner Schroth, Thomas Mürdter, Hiltrud B Brauch, Matthias Schwab, Håvard Søiland, Gunnar Mellgren, Fabienne Thomas, Charlotte Kloft, Daniel Louis Hertz, null null
Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM Cohort. Clinical pharmacology and therapeutics 116 (3) (2024)
Anna M Mc Laughlin, Cassian Yee
Letter to the editor: Quality criteria for computational models predicting individual outcomes in CAR-T cell therapy. Journal for immunotherapy of cancer 11 (4) (2023)
Anna M Mc Laughlin, Cassian Yee
Letter to the editor: Quality criteria for computational models predicting individual outcomes in CAR-T cell therapy. Journal for immunotherapy of cancer 11 (4) (2023)
Anna M Mc Laughlin, Peter A Milligan, Cassian Yee, Martin Bergstrand
Model-informed drug development of autologous CAR-T cell therapy: Strategies to optimize CAR-T cell exposure leveraging cell kinetic/dynamic modeling. CPT: pharmacometrics & systems pharmacology (2023)
Anna M Mc Laughlin, Cassian Yee
Letter to the editor: Quality criteria for computational models predicting individual outcomes in CAR-T cell therapy. Journal for immunotherapy of cancer 11 (4) (2023)
Anna M Mc Laughlin, Cassian Yee
Letter to the editor: Quality criteria for computational models predicting individual outcomes in CAR-T cell therapy. Journal for immunotherapy of cancer 11 (4) (2023)
Madelé van Dyk, Chelsea Boylan, Robin Michelet, Anna M Mc Laughlin, Ganessan Kichenadasse, Nikki May, Victoria C Ziesenitz, Johannes N Van Den Anker, Stefanie L Groenland, Alwin D R Huitema, Neeltje Steeghs, Gerd Mikus, Charlotte Kloft, Heather Tapp
Plasma concentration guided dosing of drugs used for the treatment of childhood leukaemias: protocol for a systematic review. BMJ open 12 (1) (2022)
Anna M Mc Laughlin, Nahum Puebla-Osorio, Robin Michelet, Michael R Green, Annette Künkele, Wilhelm Huisinga, Paolo Strati, Beth Chasen, Sattva S Neelapu, Cassian Yee, Charlotte Kloft
Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology Model. Cancers 13 (11) (2021)
Anna M Mc Laughlin, Lena Klopp-Schulze, Robin Michelet, Madelé van Dyk, Thomas E Mürdter, Matthias Schwab, Markus Joerger, Wilhelm Huisinga, Gerd Mikus, Charlotte Kloft
Simulation-Based Assessment of the Impact of Non-Adherence on Endoxifen Target Attainment in Different Tamoxifen Dosing Strategies. Pharmaceuticals (Basel, Switzerland) 14 (2) (2021)
Anna M Mc Laughlin, Eduard Schmulenson, Olga Teplytska, Sebastian Zimmermann, Patrick Opitz, Stefanie L Groenland, Alwin D R Huitema, Neeltje Steeghs, Lothar Müller, Stefan Fuxius, Gerald Illerhaus, Markus Joerger, Frank Mayer, Uwe Fuhr, Stefan Holdenrieder, Georg Hempel, Oliver Scherf-Clavel, Ulrich Jaehde, Charlotte Kloft, null For The On-Target Study Consortium
Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol. Cancers 13 (24) (2021)
Anna M Mc Laughlin, Robin Michelet, Lena Klopp-Schulze, Madelé van Dyk, Thomas E Mürdter, Matthias Schwab, Markus Joerger, Wilhelm Huisinga, Gerd Mikus, Charlotte Kloft
Computational Treatment Simulations to Assess the Need for Personalized Tamoxifen Dosing in Breast Cancer Patients of Different Biogeographical Groups. Cancers 13 (10) (2021)
Madelé van Dyk, Norma Bulamu, Chelsea Boylan, Anna M Mc Laughlin, Ganessan Kichenadasse, Nikki May, Robin Michelet, Charlotte Kloft, Billingsley Kaambwa
Cost-effectiveness of oral anticancer drugs and associated individualised dosing approaches in patients with cancer: protocol for a systematic review. BMJ open 11 (8) (2021)
Anna M Mc Laughlin, Robin Michelet, Ferdinand Weinelt, Charlotte Kloft, Gerd Mikus
CYP2D6 phenotype explains reported yohimbine concentrations in four severe acute intoxications. Archives of toxicology 95 (8) (2021)
Franziska Kluwe, Robin Michelet, Anna M Mc Laughlin, Corinna Maier, Lena Klopp-Schulze, Madelé van Dyk, Gerd Mikus, Wilhelm Huisinga, Charlotte Kloft
Perspectives on Model-Informed Precision Dosing in the Digital Health Era: Challenges, Opportunities, and Recommendations. Clinical pharmacology and therapeutics 109 (1) (2020)
Anna M Mc Laughlin, Lena Klopp-Schulze, Werner Schroth, Thomas Mürdter, Robin Michelet, Hiltrud B Brauch, Wilhelm Huisinga, Markus Joerger, Patrick Neven, Stijn L W Koolen, Ron H J Mathijssen, Ellen Copson, Diana Eccles, Sylvia Chen, Balram Chowbay, Arafat Tfayli, Nathalie Khoueiry Zgheib, Matthias Schwab, Charlotte Kloft
Obesity Alters Endoxifen Plasma Levels in Young Breast Cancer Patients: A Pharmacometric Simulation Approach. Clinical pharmacology and therapeutics 108 (3) (2020)

Anna M Mc Laughlin.css-eqlu8i{font-size:small;padding-left:4px;} (Anna Mueller-Schoell)

Publication Activity (10 Years)

Top Topics

Top Venues

Anna M Mc Laughlin (Anna Mueller-Schoell)